Tulsa World

FDA approves Botox to treat frown lines

FDA today announced the approval of Botulinum Toxin Type A (Botox Cosmetic) to temporarily improve the appearance of moderate to severe frown lines between the eyebrows (glabellar lines), a medical ...

Woman Gets Botox To Treat Migraines—but It Goes Horribly Wrong

Lydia August, 28, told Newsweek, "I have not shown any improvement," since the treatment was done 12 days ago.
Becker's Hospital Review

FDA approves Allergan’s Botox for forehead wrinkles: 3 things to know

The Food and Drug Administration on Tuesday approved a new use for Botox treatment. 1. Botox may now be used for the temporary improvement of moderate to severe forehead lines. 2. The drug is already ...
EurekAlert!

Climate affects dose requirements for cosmetic Botox injections

Waltham — June 30, 2024 — Patients living in "high-sun" climates may require higher doses of Botox to achieve good results in cosmetic treatment of facial lines and wrinkles, reports a study in the ...
Healio

Increased dose of Jeuveau corrects glabellar lines up to 6 months

Please provide your email address to receive an email when new articles are posted on . New phase 2 results showed 40 units of Jeuveau sustained improvements in glabellar lines up to 6 months. Adverse ...
Seeking Alpha

BOTOX® Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands)

IRVINE, Calif., Oct. 18, 2024 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie (ABBV) company, announced the U.S. FDA approval of BOTOX ® Cosmetic for temporary improvement in the appearance of ...
Seeking Alpha

AbbVie Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE (TrenibotE) for the Treatment of Glabellar Lines

–TrenibotE is a first-in-class botulinum neurotoxin serotype E characterized by a rapid onset of action as early as 8 hours after administration (earliest assessment time) and shorter duration of ...